Revolution Medicines, Inc. RVMD Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $383.75M-29.3% | $543.06M-22.0% | $696.15M+331% | $161.41M+48.8% | ||
| $1.64B-6.0% | $1.75B+51.0% | $1.16B+139% | $483.53M+3.2% | ||
| $2.08B-10.9% | $2.33B+23.9% | $1.88B+185% | $660.19M+11.9% | ||
| $33.19M+36.7% | $24.29M+6.2% | $22.87M+22.5% | $18.66M+61.6% | ||
| $14.61M0.0% | $14.61M0.0% | $14.61M0.0% | $14.61M0.0% | ||
| $55.8M-1.5% | $56.67M-1.9% | $57.74M-1.8% | $58.81M-1.8% | ||
| $2.35B-8.0% | $2.56B+24.1% | $2.06B+154% | $811.93M+10.0% | ||
| $243.73M+73.4% | $140.58M-0.4% | $141.11M+90.9% | $73.93M+65.6% | ||
| $290.42M+77.2% | $163.91M+13.9% | $143.85M+132% | $61.98M+2.7% | ||
| $723.21M+147% | $293.1M+24.5% | $235.51M+85.8% | $126.74M-6.4% | ||
| $19K+5.6% | $18K+12.5% | $16K+77.8% | $9K+12.5% | ||
| -$2.87B-65.1% | -$1.74B-52.7% | -$1.14B-62.2% | -$701.34M-54.9% | ||
| $1.63B-28.0% | $2.27B+24.0% | $1.83B+167% | $685.19M+13.7% | ||
| $2.35B-8.0% | $2.56B+24.1% | $2.06B+154% | $811.93M+10.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Revolution Medicines, Inc.'s total assets?
- Revolution Medicines, Inc. (RVMD) holds $2.3B in total assets, down 4.7% year over year.
- How much debt does Revolution Medicines, Inc. have?
- Revolution Medicines, Inc. carries $156.6M in total debt against $1.5B of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does Revolution Medicines, Inc. have?
- Revolution Medicines, Inc. holds $440.9M in cash and equivalents.
- Can Revolution Medicines, Inc. cover its short-term obligations?
- Its current ratio is 6.80 — current assets exceed current liabilities.
- Where does Revolution Medicines, Inc.'s balance sheet data come from?
- Every line is extracted from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.